The marriage between pathology and genetics: are we ready for clinical use?
作者信息
Dei Tos Angelo P
出版信息
Ann Surg Oncol. 2010 Mar;17(3):668-9. doi: 10.1245/s10434-009-0844-3.
Abstract
摘要
相似文献
1
The marriage between pathology and genetics: are we ready for clinical use?病理学与遗传学的结合：我们准备好用于临床了吗？
Ann Surg Oncol. 2010 Mar;17(3):668-9. doi: 10.1245/s10434-009-0844-3.
2
Human carcinogenesis, the new genetics, and the practicing pathologist.人类致癌作用、新遗传学与执业病理学家
Pol J Pathol. 2001;52(3):115-7.
3
Surgical pathology versus molecular biology.外科病理学与分子生物学
Int J Surg Pathol. 2001 Jan;9(1):1-3. doi: 10.1177/106689690100900101.
4
[Molecular biology and pathology. A necessary partnership].[分子生物学与病理学。一种必要的伙伴关系]
Rev Invest Clin. 2003 Mar-Apr;55(2):227-32.
5
The 2000 Long Course. Conclusion.
Mod Pathol. 2001 Mar;14(3):261-2. doi: 10.1038/modpathol.3880296.
6
Tumor biology and the surgical pathologist.
J Insur Med. 1992 Spring;24(1):69-74.
7
The new biology: histopathology.新生物学：组织病理学
Lancet. 1999 Jul;354 Suppl 1:SI26-31. doi: 10.1016/s0140-6736(99)90246-5.
8
Molecular testing of cytology specimens: Are we ready for the new era?细胞学标本的分子检测：我们是否为新时代做好准备？
Cancer Cytopathol. 2016 Jan;124(1):9-10. doi: 10.1002/cncy.21665. Epub 2015 Dec 18.
9
[Molecular biology and molecular genetics in the field of otorhinolaryngology--tumorigenesis and oncogenes].
Nihon Jibiinkoka Gakkai Kaiho. 1998 Jan;101(1):66-9. doi: 10.3950/jibiinkoka.101.66.
10
The molecular pathology of cancer. Introduction.
Cancer Surv. 1993;16:1-2.
本文引用的文献
1
Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.通过荧光原位杂交技术检测200份石蜡包埋肿瘤样本中的MDM2-CDK4扩增：在诊断脂肪细胞性病变中的应用及与免疫组织化学和实时PCR的比较
Am J Surg Pathol. 2007 Oct;31(10):1476-89. doi: 10.1097/PAS.0b013e3180581fff.
2
Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.脂肪肉瘤的基因表达谱分析确定了高分化和去分化脂肪肉瘤中不同的生物学类型/亚型以及潜在的治疗靶点。
Cancer Res. 2007 Jul 15;67(14):6626-36. doi: 10.1158/0008-5472.CAN-07-0584.
3
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.曲贝替定（ET-743）治疗晚期经治黏液样脂肪肉瘤的疗效：一项回顾性研究。
Lancet Oncol. 2007 Jul;8(7):595-602. doi: 10.1016/S1470-2045(07)70175-4.
4
Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.腹膜后脂肪肉瘤：对86例脂肪肉瘤和恶性纤维组织细胞瘤进行临床病理复查后对去分化的随访分析
Cancer. 2006 Jun 15;106(12):2725-33. doi: 10.1002/cncr.21933.
5
Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.炎症性恶性纤维组织细胞瘤和去分化脂肪肉瘤：组织学回顾、基因组概况以及MDM2和CDK4状态支持单一实体。
J Pathol. 2004 Jul;203(3):822-30. doi: 10.1002/path.1579.
6
Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.非典型脂肪瘤性肿瘤中MDM2、CDK4和HMGI-C基因的协同表达与扩增
J Pathol. 2000 Apr;190(5):531-6. doi: 10.1002/(SICI)1096-9896(200004)190:5<531::AID-PATH579>3.0.CO;2-W.
7
Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma.去分化脂肪肉瘤中p53信号通路的分子异常
J Pathol. 1997 Jan;181(1):8-13. doi: 10.1002/(SICI)1096-9896(199701)181:1<8::AID-PATH700>3.0.CO;2-#.
Zotero 插件